BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8208918)

  • 1. Screening for early ovarian cancer.
    Taylor KJ; Schwartz PE
    Radiology; 1994 Jul; 192(1):1-10. PubMed ID: 8208918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.
    Schwartz PE; Chambers JT; Taylor KJ; Pellerito J; Hammers L; Cole LA; Yang-Feng TL; Smith P; Mayne ST; Makuch R
    Yale J Biol Med; 1991; 64(6):557-71. PubMed ID: 1810100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of ovarian cancer: preliminary results of the Yale Early Detection Program.
    Schwartz PE; Chambers JT; Taylor KJ; Pellerito J; Hammers L; Cole LA; Yang-Feng TL; Smith P; Mayne ST; Makuch R
    Yale J Biol Med; 1991; 64(6):573-82. PubMed ID: 1810101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer screening.
    Kurjak A; Predanic M
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential role of serum CA 125 in an ultrasound-based screening program for familial ovarian cancer.
    Bourne TH; Campbell S; Reynolds K; Hampson J; Bhatt L; Crayford TJ; Whitehead MI; Collins WP
    Gynecol Oncol; 1994 Mar; 52(3):379-85. PubMed ID: 8157195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
    Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
    Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
    Nossov V; Amneus M; Su F; Lang J; Janco JM; Reddy ST; Farias-Eisner R
    Am J Obstet Gynecol; 2008 Sep; 199(3):215-23. PubMed ID: 18468571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for early ovarian cancer.
    Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S
    Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is early detection of ovarian cancer possible?
    Schwartz PE; Taylor KJ
    Ann Med; 1995 Oct; 27(5):519-28. PubMed ID: 8541026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of ovarian tumors by transvaginal Doppler ultrasound with color flow imaging].
    Kawai M; Maeda O; Iwata M; Oguchi H; Kojima M; Kikkawa F; Tomoda Y
    Rinsho Byori; 1992 Feb; 40(2):146-51. PubMed ID: 1583786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive acidic protein and CA 125 levels in patients with ovarian cancer.
    Castelli M; Battaglia F; Scambia G; Panici PB; Ferrandina G; Mileo AM; Mancuso S; Ferrini U
    Oncology; 1991; 48(1):13-7. PubMed ID: 1987493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer screening in a high risk population: a clinical trial.
    Taylor KJ; Schwartz PE
    Ultrasound Med Biol; 2001 Apr; 27(4):461-6. PubMed ID: 11368858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging.
    Weiner Z; Thaler I; Beck D; Rottem S; Deutsch M; Brandes JM
    Obstet Gynecol; 1992 Feb; 79(2):159-62. PubMed ID: 1731278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced ovarian cancer. Tumour markers.
    Rustin GJ; van der Burg ME; Berek JS
    Ann Oncol; 1993; 4 Suppl 4():71-7. PubMed ID: 8312203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined CA-125 test and ultrasonography in the presurgical evaluation of ovarian mass].
    Chiu SW; Ho SC; Hung YC; Lee YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Aug; 7(8):429-34. PubMed ID: 1875465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multidisciplinary approach to the early detection of ovarian carcinoma: rationale, protocol design, and early results.
    Karlan BY; Raffel LJ; Crvenkovic G; Smrt C; Chen MD; Lopez E; Walla CA; Garber C; Cane P; Sarti DA
    Am J Obstet Gynecol; 1993 Sep; 169(3):494-501. PubMed ID: 8372851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation of transvaginal Doppler studies, transvaginal sonography, magnetic resonance imaging, and CA 125 in detecting ovarian cancer.
    Hata K; Hata T; Manabe A; Sugimura K; Kitao M
    Obstet Gynecol; 1992 Dec; 80(6):922-6. PubMed ID: 1448260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumor marker--screening for gynecological cancer; personal experience. Utility of tumor markers in screening of ovarian cancer].
    Kimura E; Kobayashi S; Terashima Y
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2443-50. PubMed ID: 2260879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cancer screening: a look at the evidence.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.